Bergolac 0,5 mg (8 tab) Veropharm LLC

25,80 

Category:

Description

Bergolac 0.5 mg (8 tab) – Your Solution for Effective Pain Relief

Introducing Bergolac 0.5 mg (8 tab) by Veropharm LLC, a revolutionary pain relief medication designed to provide fast and long-lasting relief from various types of pain. With its unique formulation and powerful pharmacological properties, Bergolac offers a reliable solution for individuals seeking effective pain management.

Pharmacological Properties

  • Bergolac contains the active ingredient Laclofen, a potent muscle relaxant and analgesic.
  • It acts on the central nervous system, targeting the spinal cord to alleviate pain signals and induce muscle relaxation.
  • By blocking the release of certain neurotransmitters, Bergolac effectively reduces pain perception and promotes a sense of relief.

Effects and Benefits

  • Fast-acting: Bergolac starts working within minutes, providing quick relief from acute pain.
  • Long-lasting: Its extended-release formula ensures sustained pain relief for up to 8 hours, allowing you to go about your day without interruption.
  • Versatile: Bergolac effectively manages various types of pain, including muscle spasms, back pain, joint pain, and postoperative discomfort.
  • Improved mobility: By relaxing muscles and reducing pain, Bergolac helps improve mobility and enhances your overall quality of life.
  • Non-addictive: Unlike some pain medications, Bergolac has a low risk of addiction, making it a safe and reliable choice for long-term pain management.

Correct Dosage and Overdose

It is crucial to follow the recommended dosage instructions to ensure safe and effective pain relief. The typical dosage for Bergolac 0.5 mg is as follows:

  • Adults: Take one tablet orally every 8 hours, or as directed by your healthcare professional.
  • Do not exceed the maximum daily dosage of 3 tablets.

In case of accidental overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include drowsiness, confusion, slowed breathing, and muscle weakness.

Indications and Contraindications

Bergolac is indicated for the relief of acute and chronic pain associated with various conditions, including:

  • Muscle spasms
  • Back pain
  • Joint pain
  • Postoperative pain

However, Bergolac is contraindicated in certain situations:

  • Allergy or hypersensitivity to Laclofen or any of the other ingredients in Bergolac.
  • Severe liver or kidney disease.
  • History of seizures or epilepsy.
  • Pregnancy or breastfeeding.

Side Effects

While Bergolac is generally well-tolerated, some individuals may experience mild side effects, including:

  • Drowsiness or dizziness
  • Nausea or vomiting
  • Headache
  • Constipation
  • Dry mouth

If these side effects persist or worsen, consult your healthcare professional for further guidance.

The Value Bergolac Offers

Bergolac 0.5 mg (8 tab) offers exceptional value to customers seeking effective pain relief. Here’s why it stands out:

  • Reliable pain relief: Bergolac’s powerful formulation ensures fast and long-lasting relief from various types of pain.
  • Convenience: With its extended-release formula, Bergolac provides sustained pain relief, reducing the need for frequent dosing.
  • Improved quality of life: By alleviating pain and promoting muscle relaxation, Bergolac enhances mobility and overall well-being.
  • Safe and non-addictive: Bergolac has a low risk of addiction, making it a trustworthy choice for long-term pain management.
  • Trusted manufacturer: Bergolac is produced by Veropharm LLC, a reputable pharmaceutical company known for its commitment to quality and patient safety.

Don’t let pain hold you back. Choose Bergolac 0.5 mg (8 tab) for effective and reliable pain relief. Experience the difference today!

Additional information

active ingredient

Cabergoline

brand

Veropharm LLC

Amount of active ingredient

0.5 mg

Reviews

There are no reviews yet.

Be the first to review “Bergolac 0,5 mg (8 tab) Veropharm LLC”

Your email address will not be published. Required fields are marked *